Latest Algae Biosciences (AGBCF) Headlines
Omega-3 Polyunsaturated Fatty Acids (PUFAs) - 2014 Global Market Overview
M2 - Tue Feb 25, 3:30AM CST
Research and Markets (http://www.researchandmarkets.com/research/mb5wq7/omega3) has announced the addition of the "Omega-3 Polyunsaturated Fatty Acids (PUFAs) - A Global Market Overview" report to their offering. Pharmaceutical drugs, by default, have started incorporating higher concentrations of omega-3 and it is anticipated that, over the coming few years, several new companies would be jumping on to the bandwagon of omega-3 drugs. Several drugs are in Phase II or Phase III clinical trials, with several more expected to come on-stream quite soon. However, the coming year or two is likely to witness an influx of new companies invading the global omega-3 market, provided they obtain the USFDA's or other relevant authorities' approvals. In a global scenario where increasing attention is being directed towards issues of sustainability and limited food supplies, algal sources offer immense scope for the rapidly expanding omega-3 market to continue in the same vein. The focus on obtaining EPA and DHA from algae was prompted by an endeavor to seek out more sustainable sources, since EPA and DHA are naturally contained in algae. Moreover, the omega-3 content in fish and krill originates from their consuming the algae directly or other creatures that feed on algae. In addition to being sustainable, algae also allows for farming that can be of help in putting up desirable labels, such as vegetarian, kosher or even organic. The past several decades have been witness to research studies that have underscored the significance of omega-3 fatty acids in maintaining heart health, in addition to safeguarding against cancer and birth defects and offsetting symptoms of diabetes, arthritis, cognitive decline, depression and several other conditions. Omega-3 Polyunsaturated Fatty Acids (PUFAs) have been growing and continues to grow significantly in the future, attributed to the above benefits. The report reviews, analyses and projects the market of marine and algal omega-3 polyunsaturated fatty acid ingredients for global and the regional markets including North America, Europe, Asia-Pacific and Rest of World. The regional markets further analyzed for 13 independent countries. Omega-3 Polyunsaturated Fatty Acid (PUFAs) ingredients market analyzed in this study include EPA and DHA omega-3s from marine oils such as fish oils, krill oils and squid oils; and algal oils. The end use application markets covered in the report include dietary supplements, food & beverages, pet nutrition, infant nutrition, pharmaceuticals and clinical nutrition. Worldwide, consumption of Omega-3 polyunsaturated fatty acids (PUFAs), estimated at 123.8 thousand metric tons worth US$2.3 billion in 2013, is forecast to be 134.7 thousand metric tons valued at US$2.5 billion in 2014. By 2020, it is projected that demand for Omega-3 PUFAs globally would reach 241 thousand metric tons with a value of US$4.96 billion, thereby posting a volume CAGR of almost 10% and a value CAGR of 11.6% between 2013 and 2020. Key Topics Covered Part A: Global Market Perspective 1. Introduction 2. Global Regulatory Landscape For Omega-3 Fatty Acids 3. Key Market Trends 4. Industry Structure And Competetive Landscape 5. Key Global Players 6. Key Business Trends 7. Key Product/Technology Trends 8. Global Market Overview Part B: Regional Market Perspective 1. Global Omega-3 Pufas Market Overview By Geographic Region 2. Global Marine Omega-3 Pufas Market Overview By Geographic Region 3. Global Algal Omega-3 Pufas Market Overview By Geographic Region 4. Global Omega-3 Pufas End-Use Application Market Overview By Geographic Region Regional Market Overview 1. North America 2. Europe 3. Asia-Pacific 4. Rest Of World Part C: Omega-3 Patent Landscape 1. Fish Oil Omega-3 Fatty Acids 2. Algal Oil Omega-3 Fatty Acids Part D: Guide To The Industry 1. Manufacturers Of Omega 3 Ingredients 2. Pharma Companies In Omega 3 Drugs Market 3. Raw Material Producers, Omega 3 End Users And Other Related Companies In Omega 3 Industry 4. Major Ingredient Distributors Part E: Annexure 1. Research Methodology 2. The Questionnaire 3. Feedback Companies Mentioned Examples of companies mentioned include: - Acasti Pharma - Aker Biomarine - Algae Biosciences - Aurora Algae - Ayanda - BASF - Chemport - Croda International - GC Rieber Oils - Golden Omega - Hubei Fuxing Biotechnology - Jiangsu Auqi Marine Biotechnology - Marine Ingredients - Maruha Nichiro Foods - Neptune Technologies & Bioressources - Nippon Suisan Kaisha(Nissui) - Olvea Fish Oils (Olvea Group) - Omega Protein - Pharma Marine - Polaris Nutritional Lipids - Qualitas Health - Sinomega Biotech Engineering - Smit Functional Oils (Smit & Zoon Group) - Solutex GC - Source-Omega - Stepan - TASA Omega (Tecnol?gica De Alimentos) - Zhejiang Shenzhou Marine Bio-Tech ... and more For more information visit http://www.researchandmarkets.com/research/mb5wq7/omega3 About Research and Markets Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products.
TSX Venture Exchange Daily Bulletins
CNW Group - Mon Jan 06, 4:07PM CST
TSX VENTURE COMPANIES:
Algae Biosciences Corporation Announces Resignation of CEO and CFO and Appointment of New CEO and CFO
Newsfile Corp - Fri Jun 28, 6:25PM CDT
full story)
Algae Biosciences Corporation Closes Private Placement Financing
Newsfile Corp - Fri Jun 14, 4:01PM CDT
full story)
Algae Biosciences Announces Management Services Agreement
Newsfile Corp - Thu May 23, 7:13PM CDT
Algae Biosciences Corporation ("AlgaeBio" or the "Company") (TSXV: ABV) is pleased to announce that it has entered into an agreement effective May 21, 2013, with Ward Marlatte and Wayne Tinker o/a Spinnaker Ventures Limited/Spinnaker Securities Limited ("Spinnaker") of Calgary, Alberta, with respect to the provision of corporate finance and management advisory services to the Company, in regards to assisting the Company:
Algae Biosciences Comments on Recent Trading Activity
GlobeNewswire - Mon Dec 17, 1:59PM CST
Algae Biosciences Corporation (TSX-V:ABV) ("AlgaeBio" or the "Company") announces that the Company is aware of the unusually active trading activity in its common stock and wishes to inform the investment community that all material events concerning the Company have been fully disclosed in previous press releases and other required filings. AlgaeBio Chairman Robert Thompson commented: "In our most recent corporate update released on November 28, 2012, we reported that the installed bioreactors systems are performing to specification with no scale-up issues. This continues to be the case."
Omega-3 Polyunsaturated Fatty Acids (PUFAs) - 2014 Global Market Overview
M2 - Tue Feb 25, 3:30AM CST
Research and Markets (http://www.researchandmarkets.com/research/mb5wq7/omega3) has announced the addition of the "Omega-3 Polyunsaturated Fatty Acids (PUFAs) - A Global Market Overview" report to their offering. Pharmaceutical drugs, by default, have started incorporating higher concentrations of omega-3 and it is anticipated that, over the coming few years, several new companies would be jumping on to the bandwagon of omega-3 drugs. Several drugs are in Phase II or Phase III clinical trials, with several more expected to come on-stream quite soon. However, the coming year or two is likely to witness an influx of new companies invading the global omega-3 market, provided they obtain the USFDA's or other relevant authorities' approvals. In a global scenario where increasing attention is being directed towards issues of sustainability and limited food supplies, algal sources offer immense scope for the rapidly expanding omega-3 market to continue in the same vein. The focus on obtaining EPA and DHA from algae was prompted by an endeavor to seek out more sustainable sources, since EPA and DHA are naturally contained in algae. Moreover, the omega-3 content in fish and krill originates from their consuming the algae directly or other creatures that feed on algae. In addition to being sustainable, algae also allows for farming that can be of help in putting up desirable labels, such as vegetarian, kosher or even organic. The past several decades have been witness to research studies that have underscored the significance of omega-3 fatty acids in maintaining heart health, in addition to safeguarding against cancer and birth defects and offsetting symptoms of diabetes, arthritis, cognitive decline, depression and several other conditions. Omega-3 Polyunsaturated Fatty Acids (PUFAs) have been growing and continues to grow significantly in the future, attributed to the above benefits. The report reviews, analyses and projects the market of marine and algal omega-3 polyunsaturated fatty acid ingredients for global and the regional markets including North America, Europe, Asia-Pacific and Rest of World. The regional markets further analyzed for 13 independent countries. Omega-3 Polyunsaturated Fatty Acid (PUFAs) ingredients market analyzed in this study include EPA and DHA omega-3s from marine oils such as fish oils, krill oils and squid oils; and algal oils. The end use application markets covered in the report include dietary supplements, food & beverages, pet nutrition, infant nutrition, pharmaceuticals and clinical nutrition. Worldwide, consumption of Omega-3 polyunsaturated fatty acids (PUFAs), estimated at 123.8 thousand metric tons worth US$2.3 billion in 2013, is forecast to be 134.7 thousand metric tons valued at US$2.5 billion in 2014. By 2020, it is projected that demand for Omega-3 PUFAs globally would reach 241 thousand metric tons with a value of US$4.96 billion, thereby posting a volume CAGR of almost 10% and a value CAGR of 11.6% between 2013 and 2020. Key Topics Covered Part A: Global Market Perspective 1. Introduction 2. Global Regulatory Landscape For Omega-3 Fatty Acids 3. Key Market Trends 4. Industry Structure And Competetive Landscape 5. Key Global Players 6. Key Business Trends 7. Key Product/Technology Trends 8. Global Market Overview Part B: Regional Market Perspective 1. Global Omega-3 Pufas Market Overview By Geographic Region 2. Global Marine Omega-3 Pufas Market Overview By Geographic Region 3. Global Algal Omega-3 Pufas Market Overview By Geographic Region 4. Global Omega-3 Pufas End-Use Application Market Overview By Geographic Region Regional Market Overview 1. North America 2. Europe 3. Asia-Pacific 4. Rest Of World Part C: Omega-3 Patent Landscape 1. Fish Oil Omega-3 Fatty Acids 2. Algal Oil Omega-3 Fatty Acids Part D: Guide To The Industry 1. Manufacturers Of Omega 3 Ingredients 2. Pharma Companies In Omega 3 Drugs Market 3. Raw Material Producers, Omega 3 End Users And Other Related Companies In Omega 3 Industry 4. Major Ingredient Distributors Part E: Annexure 1. Research Methodology 2. The Questionnaire 3. Feedback Companies Mentioned Examples of companies mentioned include: - Acasti Pharma - Aker Biomarine - Algae Biosciences - Aurora Algae - Ayanda - BASF - Chemport - Croda International - GC Rieber Oils - Golden Omega - Hubei Fuxing Biotechnology - Jiangsu Auqi Marine Biotechnology - Marine Ingredients - Maruha Nichiro Foods - Neptune Technologies & Bioressources - Nippon Suisan Kaisha(Nissui) - Olvea Fish Oils (Olvea Group) - Omega Protein - Pharma Marine - Polaris Nutritional Lipids - Qualitas Health - Sinomega Biotech Engineering - Smit Functional Oils (Smit & Zoon Group) - Solutex GC - Source-Omega - Stepan - TASA Omega (Tecnol?gica De Alimentos) - Zhejiang Shenzhou Marine Bio-Tech ... and more For more information visit http://www.researchandmarkets.com/research/mb5wq7/omega3 About Research and Markets Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products.
TSX Venture Exchange Daily Bulletins
CNW Group - Mon Jan 06, 4:07PM CST
TSX VENTURE COMPANIES:
Algae Biosciences Corporation Announces Resignation of CEO and CFO and Appointment of New CEO and CFO
Newsfile Corp - Fri Jun 28, 6:25PM CDT
full story)
Algae Biosciences Corporation Closes Private Placement Financing
Newsfile Corp - Fri Jun 14, 4:01PM CDT
full story)
Algae Biosciences Announces Management Services Agreement
Newsfile Corp - Thu May 23, 7:13PM CDT
Algae Biosciences Corporation ("AlgaeBio" or the "Company") (TSXV: ABV) is pleased to announce that it has entered into an agreement effective May 21, 2013, with Ward Marlatte and Wayne Tinker o/a Spinnaker Ventures Limited/Spinnaker Securities Limited ("Spinnaker") of Calgary, Alberta, with respect to the provision of corporate finance and management advisory services to the Company, in regards to assisting the Company:
Algae Biosciences Comments on Recent Trading Activity
GlobeNewswire - Mon Dec 17, 1:59PM CST
Algae Biosciences Corporation (TSX-V:ABV) ("AlgaeBio" or the "Company") announces that the Company is aware of the unusually active trading activity in its common stock and wishes to inform the investment community that all material events concerning the Company have been fully disclosed in previous press releases and other required filings. AlgaeBio Chairman Robert Thompson commented: "In our most recent corporate update released on November 28, 2012, we reported that the installed bioreactors systems are performing to specification with no scale-up issues. This continues to be the case."
